Thomas P Koestler - Net Worth and Insider Trading

Thomas P Koestler Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Thomas P Koestler owns 4 companies in total, including Momenta Pharmaceuticals Inc (MNTA) , Melinta Therapeutics Inc (MLNTQ) , and Merck & Co Inc (MRK) among others .

Click here to see the complete history of Thomas P Koestler’s form 4 insider trades.

Insider Ownership Summary of Thomas P Koestler

Ticker	Company	Transaction Date	Type of Owner
MNTA	Momenta Pharmaceuticals Inc	2019-06-19	director
MLNTQ	Melinta Therapeutics Inc	2019-06-11	director
MRK	Merck & Co Inc	2006-09-01	Executive Vice President
		2006-09-01	Executive Vice President

Thomas P Koestler Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Thomas P Koestler Ownership Network

Ownership Network List of Thomas P Koestler

No Data

Ownership Network Relation of Thomas P Koestler

Thomas P Koestler Owned Company Details

What does Momenta Pharmaceuticals Inc do?

Who are the key executives at Momenta Pharmaceuticals Inc?

Thomas P Koestler is the director of Momenta Pharmaceuticals Inc. Other key executives at Momenta Pharmaceuticals Inc include Chief Legal Officer Alejandra Carvajal , Chief Scientific Officer Anthony M. Manning , and SVP & Chief Medical Officer Santiago Arroyo .

Momenta Pharmaceuticals Inc (MNTA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Momenta Pharmaceuticals Inc (MNTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Momenta Pharmaceuticals Inc (MNTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Momenta Pharmaceuticals Inc (MNTA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Momenta Pharmaceuticals Inc Insider Transactions

No Available Data

What does Melinta Therapeutics Inc do?

Who are the key executives at Melinta Therapeutics Inc?

Thomas P Koestler is the director of Melinta Therapeutics Inc. Other key executives at Melinta Therapeutics Inc include director & Chief Executive Officer John Johnson , director & See Remarks Daniel Mark Wechsler , and Chief Commercial Officer John Temperato .

Melinta Therapeutics Inc (MLNTQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Melinta Therapeutics Inc (MLNTQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Melinta Therapeutics Inc (MLNTQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Melinta Therapeutics Inc (MLNTQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Melinta Therapeutics Inc Insider Transactions

No Available Data

What does Merck & Co Inc do?

Who are the key executives at Merck & Co Inc?

Thomas P Koestler is the Executive Vice President of Merck & Co Inc. Other key executives at Merck & Co Inc include SVP & U.S. Market Johannes Jacobus Oosthuizen , EVP,Chief Info&Digital Officer David Michael Williams , and Chief Comm. & Public Afrs Ofcr Cristal N Downing .

Merck & Co Inc (MRK) Insider Trades Summary

Over the past 18 months, Thomas P Koestler made no insider transaction in Merck & Co Inc (MRK). Other recent insider transactions involving Merck & Co Inc (MRK) include a net sale of 27,459 shares made by Johannes Jacobus Oosthuizen , a net sale of 7,451 shares made by David Michael Williams , and a net sale of 235,021 shares made by Robert M Davis .

In summary, during the past 3 months, insiders sold 18,762 shares of Merck & Co Inc (MRK) in total and bought 0 shares, with a net sale of 18,762 shares. During the past 18 months, 330,547 shares of Merck & Co Inc (MRK) were sold and 17,833 shares were bought by its insiders, resulting in a net sale of 312,714 shares.

Merck & Co Inc (MRK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Merck & Co Inc Insider Transactions

No Available Data

What does Merck & Co Inc do?

Who are the key executives at Merck & Co Inc?

Thomas P Koestler is the Executive Vice President of Merck & Co Inc. Other key executives at Merck & Co Inc include President & Human Health Int?l Joseph Romanelli , Chief Marketing Officer Chirfi Guindo , and SVP & U.S. Market Johannes Jacobus Oosthuizen .

Merck & Co Inc (MRKPRB.PFD) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Merck & Co Inc (MRKPRB.PFD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Merck & Co Inc (MRKPRB.PFD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Merck & Co Inc (MRKPRB.PFD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Merck & Co Inc Insider Transactions

No Available Data

Thomas P Koestler Mailing Address

Above is the net worth, insider trading, and ownership report for Thomas P Koestler. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Thomas P Koestler's mailing address is: Kenilworth Nj 07033.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.